Metraipolis › archive › dc_96fe92fdfb82

Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated… — Europe PMC PMID:42207829

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42207829
DOI
10.1371/journal.pone.0350263
License (as archived)
solo-consultazione
Archived
2026-11-01T03:37:41.277Z
SHA-256 of the archived text
3ba870679db70957f5be0fb6c33c88eaa43913ea0c7211d12abc2c6cae48f4ab
Stable URL of this page
https://metraipolis.com/documento/dc_96fe92fdfb82

How to cite

Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated… — Europe PMC PMID:42207829 — Europe PMC (en), https://europepmc.org/article/MED/42207829 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96fe92fdfb82 (Metraipolis archive dc_96fe92fdfb82, sha256 3ba870679db70957f5be0fb6c33c88eaa43913ea0c7211d12abc2c6cae48f4ab)
BibTeX
@misc{dc96fe92fdfb82,
  title = {Cost-effectiveness of various referral pathways to identify advanced fibrosis among type 2 diabetes mellitus patients with metabolic dysfunction-associated… — Europe PMC PMID:42207829},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42207829},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96fe92fdfb82; sha256 3ba870679db70957f5be0fb6c33c88eaa43913ea0c7211d12abc2c6cae48f4ab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42207829. Agents can read the archived copy with the MCP tool read_document.